Biovie Financial Statements From 2010 to 2024

BIVI Stock  USD 3.05  0.06  1.93%   
Biovie financial statements provide useful quarterly and yearly information to potential Biovie Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Biovie financial statements helps investors assess Biovie's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Biovie's valuation are summarized below:
Market Capitalization
54.2 M
Earnings Share
(5.08)
We have found one hundred twenty available fundamental signals for Biovie Inc, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Biovie Inc prevailing fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year.
Check Biovie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biovie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 193.4 K, Interest Expense of 1.4 M or Selling General Administrative of 13.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.23 or PTB Ratio of 1.15. Biovie financial statements analysis is a perfect complement when working with Biovie Valuation or Volatility modules.
  
Check out the analysis of Biovie Correlation against competitors.

Biovie Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets26.5 M25.2 M8.5 M
Slightly volatile
Total Current Liabilities5.1 M9.4 M4.1 M
Slightly volatile
Accounts Payable3.8 M3.6 M783.6 K
Slightly volatile
Cash25 M23.8 M6.3 M
Slightly volatile
Cash And Short Term Investments25 M23.8 M7.2 M
Slightly volatile
Common Stock Total Equity2.1 K2.2 K8.9 K
Pretty Stable
Liabilities And Stockholders Equity26.5 M25.2 M8.5 M
Slightly volatile
Other Stockholder Equity367.2 M349.7 M104 M
Slightly volatile
Total Liabilities6.9 M9.7 M5.5 M
Slightly volatile
Total Current Assets25.3 M24 M7.3 M
Slightly volatile
Common StockK6.2 K9.7 K
Very volatile
Common Stock Shares Outstanding4.7 M4.5 MM
Slightly volatile
Short and Long Term Debt Total5.4 M6.1 M3.5 M
Slightly volatile
Capital Stock3.1 K3.3 K31.5 K
Slightly volatile

Biovie Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization193.4 K229.4 K141.9 K
Slightly volatile
Interest Expense1.4 M1.8 MM
Slightly volatile
Selling General Administrative13.9 M13.3 MM
Slightly volatile
Other Operating Expenses25.3 M32.2 M18.6 M
Slightly volatile
Research Development21 M23.1 M15.4 M
Slightly volatile
Total Operating Expenses25.2 M32 M18.6 M
Slightly volatile
Interest Income678.9 K646.6 K130.4 K
Slightly volatile
Reconciled Depreciation183.5 K206.4 K224.8 K
Slightly volatile

Biovie Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow20.4 M19.5 M4.4 M
Slightly volatile
Depreciation198.8 K263.8 K158.3 K
Slightly volatile
End Period Cash Flow25 M23.8 M6.2 M
Slightly volatile
Change To Netincome16.2 M11.4 M11.6 M
Slightly volatile
Other Cashflows From Financing Activities15.3 M14.5 M4.8 M
Slightly volatile
Stock Based Compensation2.6 M4.7 M1.6 M
Slightly volatile
Issuance Of Capital Stock66.9 M63.7 M17.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield0.230.220.0972
Slightly volatile
Average Payables1.9 M1.8 M537 K
Slightly volatile
Payables Turnover0.06080.063911.7865
Slightly volatile
Cash Per Share5.035.27696.0386
Slightly volatile
Days Payables OutstandingK5.7 K2.1 K
Pretty Stable
Income Quality0.910.870.4575
Slightly volatile
Intangibles To Total Assets0.02840.02990.6409
Slightly volatile
Current Ratio4.812.57148.309
Slightly volatile
Graham Number22.2623.428253.7683
Pretty Stable
Interest Debt Per Share1.571.65063.1793
Slightly volatile
Debt To Assets0.260.22620.2426
Slightly volatile
Days Of Payables OutstandingK5.7 K2.1 K
Pretty Stable
Ebt Per Ebit1.140.99821.3463
Pretty Stable
Quick Ratio4.812.57148.309
Slightly volatile
Net Income Per E B T0.990.91.0904
Pretty Stable
Cash Ratio4.622.54958.1671
Slightly volatile
Debt Ratio0.260.22620.2426
Slightly volatile

Biovie Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap15.1 M17 M18.5 M
Slightly volatile
Enterprise Value887.9 K998.9 K1.1 M
Slightly volatile

Biovie Fundamental Market Drivers

Cash And Short Term Investments23.8 M

Biovie Upcoming Events

9th of February 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of August 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About Biovie Financial Statements

Investors use fundamental indicators, such as Biovie's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biovie's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-3.6 M-3.4 M
Cost Of Revenue229.4 K142.2 K

Currently Active Assets on Macroaxis

When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:
Check out the analysis of Biovie Correlation against competitors.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.08)
Return On Assets
(0.67)
Return On Equity
(2.08)
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.